LKB1 Loss Is Associated with Resistance to Anti-Angiogenic Therapy in Non-Small Cell Lung Cancer Mouse Models

被引：0
|
作者：
Guijarro, I. [1 ]
Poteete, A. [1 ]
Fan, Y. [1 ]
Cho, S. [1 ]
Tong, P. [1 ]
Roarty, E. [1 ]
Nilsson, M. [1 ]
Rodriguez-Canales, J. [2 ]
Mino, B. [2 ]
Cuentas, E. Parra [2 ]
Wistuba, I. [2 ]
Wang, J. [3 ]
Heymach, J. [4 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[2] MD Anderson, Translat Mol Pathol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
LKB1; Anti-angiogenic therapy; Resistance;
D O I：
10.1016/j.jtho.2017.09.1654
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.03-027
引用
收藏
页码：S2283 / S2283
页数：1
相关论文
共 50 条
  • [21] Pericytes from human non-small cell lung carcinomas: An attractive target for anti-angiogenic therapy
    Bagley, Rebecca G.
    Rouleau, Cecile
    Morgenbesser, Sharon D.
    Weber, William
    Cook, Brian P.
    Shankara, Srinivas
    Madden, Stephen L.
    Teicher, Beverly A.
    MICROVASCULAR RESEARCH, 2006, 71 (03) : 163 - 174
  • [22] Predictive factors for combined anti-PD-1 and anti-angiogenic therapy in multiline treatment of advanced non-small cell lung cancer.
    Wang, Yina
    Li, Xiaobin
    Chen, Yao
    Xu, Mingyan
    Song, Lele
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [23] LKB1 mutations are extremely rare in Korean non-small cell lung cancers
    Kim, Min Jung
    Jin, Guang
    Jheon, Hyo-Sung
    Lee, Sin Yup
    Cha, Sung Ick
    Kim, Chang Ho
    Jung, Tae Noon
    Park, Jae Yong
    CANCER GENETICS AND CYTOGENETICS, 2010, 196 (02) : 204 - 206
  • [24] Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer
    Liang, Hongge
    Wang, Mengzhao
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7707 - 7719
  • [25] Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancer
    Ha Choi, Sun
    Do, Sook Kyung
    Lee, Shin Yup
    Choi, Jin Eun
    Kang, Hyo-Gyoung
    Hong, Mi Jeong
    Lee, Jang Hyuck
    Lee, Won Kee
    Jeong, Ji Yun
    Shin, Kyung Min
    Do, Young Woo
    Lee, Eung Bae
    Park, Ji Eun
    Lee, Yong Hoon
    Seo, Hyewon
    Yoo, Seung Soo
    Lee, Jaehee
    Cha, Seung Ick
    Kim, Chang Ho
    Park, Jae Yong
    THORACIC CANCER, 2022, 13 (23) : 3322 - 3330
  • [26] Glucocorticoid mediated inhibition of LKB1 mutant non-small cell lung cancers
    Huffman, Kenneth E.
    Li, Long Shan
    Carstens, Ryan
    Park, Hyunsil
    Girard, Luc
    Avila, Kimberley
    Wei, Shuguang
    Kollipara, Rahul
    Timmons, Brenda
    Sudderth, Jessica
    Bendris, Nawal
    Kim, Jiyeon
    Villalobos, Pamela
    Fujimoto, Junya
    Schmid, Sandra
    Deberardinis, Ralph J.
    Wistuba, Ignacio
    Heymach, John
    Kittler, Ralf
    Akbay, Esra A.
    Posner, Bruce
    Wang, Yuzhuo
    Lam, Stephen
    Kliewer, Steven A.
    Mangelsdorf, David J.
    Minna, John D.
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Blocking CD47 efficiently potentiated therapeutic effects of anti-angiogenic therapy in non-small cell lung cancer
    Zhang, Xuyao
    Wang, Yichen
    Fan, Jiajun
    Chen, Wei
    Luan, Jingyun
    Mei, Xiaobin
    Wang, Shaofei
    Li, Yubin
    Ye, Li
    Li, Song
    Tian, Wenzhi
    Yin, Kai
    Ju, Dianwen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [28] Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy
    Nunzia Tacelli
    Teresa Santangelo
    Arnaud Scherpereel
    Alain Duhamel
    Valérie Deken
    Ernst Klotz
    Alexis Cortot
    Jean-Jacques Lafitte
    Frédéric Wallyn
    Jacques Remy
    Martine Remy-Jardin
    European Radiology, 2013, 23 : 2127 - 2136
  • [29] Perfusion CT allows prediction of therapy response in non-small cell lung cancer treated with conventional and anti-angiogenic chemotherapy
    Tacelli, Nunzia
    Santangelo, Teresa
    Scherpereel, Arnaud
    Duhamel, Alain
    Deken, Valerie
    Klotz, Ernst
    Cortot, Alexis
    Lafitte, Jean-Jacques
    Wallyn, Frederic
    Remy, Jacques
    Remy-Jardin, Martine
    EUROPEAN RADIOLOGY, 2013, 23 (08) : 2127 - 2136
  • [30] LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer
    Lagoudaki, Eleni D.
    Koutsopoulos, Anastasios V.
    Sfakianaki, Maria
    Papadaki, Chara
    Manikis, Georgios C.
    Voutsina, Alexandra
    Trypaki, Maria
    Tsakalaki, Eleftheria
    Fiolitaki, Georgia
    Hatzidaki, Dora
    Yiachnakis, Emmanuel
    Koumaki, Dimitra
    Mavroudis, Dimitrios
    Tzardi, Maria
    Stathopoulos, Efstathios N.
    Marias, Kostas
    Georgoulias, Vassilis
    Souglakos, John
    CANCERS, 2024, 16 (10)
12345